摘要
目的研究小儿支原体肺炎临床治疗中阿奇霉素与红霉素两种药物应用的不同效果。方法随机将2017年6月—2018年12月收治的100例支原体肺炎小儿分为两组,阿奇霉素组50例应用阿奇霉素治疗,红霉素组50例应用红霉素治疗,比较两组症状改善、不良反应发生情况。结果阿奇霉素组治疗后发热消退、咳嗽消失、肺部啰音消失及X线阴影消失时间短于红霉素组,差异有统计学意义(P<0.05);阿奇霉素组治疗后不良反应发生率为10.00%,红霉素组不良反应发生率26.00%,差异有统计学意义(χ^2=4.336,P<0.05)。结论阿奇霉素治疗小儿支原体肺炎能够较红霉素更明显改善症状,减少不良反应。
Objective To study the different effects of azithromycin and erythromycin in the clinical treatment of mycoplasmal pneumonia in children.Methods 100 children with mycoplasmal pneumonia were randomly divided into 2 groups from June 2017 to December 2018.50 patients in the azithromycin group were treated with azithromycin,and 50 patients in the erythromycin group were treated with erythromycin.Comparing the symptoms improvement and adverse reations of the two groups.Results After treatment,the fever in the azithromycin group disappeared,the cough disappeared,the lungs disappeared,and the X-ray shadow disappeared shorter than the erythromycin group,the different was statistically significant(P<0.05).The incidence of adverse reactions after treatment in the azithromycin group was 10.00%.The incidence of adverse reactions was 26.00%,the difference was statistically significant(χ^2=4.336,P<0.05).Conclusion Azithromycin can significantly improve symptoms and reduce adverse reactions in children with mycoplasmal pneumonia.
作者
孙琴
SUN Qin(Department of Pediatrics,Jiangdu Maternal and Child Health Hospital,Yangzhou,Jiangsu Province,225200 China)
出处
《世界复合医学》
2019年第9期169-171,共3页
World Journal of Complex Medicine
关键词
小儿支原体肺炎
阿奇霉素
红霉素
治疗
Pediatric mycoplasmal pneumonia
Azithromycin
Erythromycin
Treatment
